The relationship between clinical progression and cortical atrophy progression seems, therefore, closer than that between cognitive decline and the evolution of tau-PET SUVr values, whereas the predictive value of baseline tau SUVr values on subsequent cognitive decline appears better than that of brain atrophy, as previously reported [7]. The gene discussed is MAPT; the disease is Mental deterioration.